A doxycycline-treated group and a control group of engrafted human MHCC97H cells of hepatocellular carcinoma into BALB/c mice showed that doxycycline acted as an MMP-2 and MMP-9 inhibitor [30]. This evidence concerns the gene MMP9 and hepatocellular carcinoma.